Intestinal Infections by Escherichia coli: Complete ICD-11 Coding Guide

1. Introduction

Intestinal infections caused by Escherichia coli represent one of the most significant causes of acute diarrheal disease worldwide, affecting millions of people annually. Escherichia coli is a gram-negative bacterium that normally inhabits the human intestinal tract as a commensal organism; however, certain pathogenic strains have developed virulence mechanisms capable of causing everything from self-limited diarrhea to severe conditions with potentially fatal complications.

The clinical importance of these infections transcends individual morbidity, constituting a significant challenge for global public health. Infections caused by pathogenic E. coli are frequently associated with epidemic outbreaks related to contamination of food and water, particularly affecting vulnerable populations such as young children, elderly individuals, and immunocompromised persons. The severity of clinical presentations varies considerably depending on the pathotype involved, ranging from enterotoxigenic E. coli causing "traveler's diarrhea" to enterohemorrhagic E. coli producing Shiga toxin, associated with hemolytic-uremic syndrome.

Correct coding of these infections in the ICD-11 system is fundamental for multiple purposes: effective epidemiological surveillance, outbreak identification, appropriate allocation of public health resources, scientific research, and adequate clinical management. The code 1A03 was specifically designated to capture all gastrointestinal manifestations caused by this bacterium, allowing precise tracking and international comparability of health data. Clear distinction between this code and other bacterial intestinal infections is essential for healthcare professionals, clinical coders, and health information system managers.

2. Correct ICD-11 Code

Code: 1A03

Description: Intestinal infections due to Escherichia coli

Parent category: Bacterial intestinal infections

Official definition: Any condition of the gastrointestinal system caused by infection with the gram-negative bacterium Escherichia coli.

This code was developed to encompass the entire spectrum of gastrointestinal manifestations caused by pathogenic strains of E. coli, regardless of the specific mechanism of pathogenicity. The classification recognizes that different pathotypes (enterotoxigenic, enterohemorrhagic, enteropathogenic, enteroinvasive, enteroaggregative, and diffuse adherence) share the common etiologic agent but may present distinct clinical manifestations.

The inclusion of this code in the category of bacterial intestinal infections reflects the primarily gastrointestinal nature of these infections, although systemic complications may occur. The code allows for additional subcategorization when it is necessary to identify specific pathotypes or particular clinical manifestations, providing flexibility for detailed clinical documentation while maintaining the ability to aggregate data for epidemiological purposes.

The hierarchical structure of ICD-11 positions this code to facilitate both clinical coding and public health analyses, allowing information systems to capture the necessary specificity without compromising international comparability of morbidity data related to E. coli.

3. When to Use This Code

Code 1A03 should be used in specific clinical situations where there is confirmation or strong clinical suspicion of intestinal infection by Escherichia coli. Below, we present detailed practical scenarios:

Scenario 1: Confirmed Traveler's Diarrhea A patient presents with acute watery diarrhea, abdominal cramps, and nausea beginning 48 hours after consuming food in an area with poor sanitary conditions. Stool culture identifies enterotoxigenic E. coli (ETEC). This is a classic case for application of code 1A03, as there is laboratory confirmation of the etiologic agent and compatible gastrointestinal manifestations.

Scenario 2: Epidemic Outbreak with Identification of E. coli O157:H7 During investigation of an outbreak related to consumption of contaminated food, multiple patients develop bloody diarrhea and severe abdominal cramps. Laboratory tests confirm Shiga toxin-producing E. coli (STEC/EHEC). All confirmed cases should receive code 1A03, with possible additional subcategorization if the system allows serotype specification.

Scenario 3: Infantile Gastroenteritis with EPEC Isolation An 8-month-old infant presents with persistent watery diarrhea, vomiting, and signs of moderate dehydration. Etiologic investigation through stool culture or PCR identifies enteropathogenic E. coli (EPEC). Code 1A03 is appropriate even in the absence of initial confirmation, and may be applied based on clinical suspicion and later confirmed with laboratory results.

Scenario 4: Hemorrhagic Colitis without Complications An adult patient develops initially watery diarrhea that progresses to bloody after 2-3 days, accompanied by intense abdominal pain but without significant fever. Even before laboratory confirmation, if the clinical presentation is strongly suggestive of EHEC infection and other causes have been reasonably excluded, code 1A03 may be applied provisionally.

Scenario 5: Persistent Diarrhea from Enteroaggregative E. coli A child presents with prolonged watery diarrhea (more than 14 days) with weight loss, unresponsive to initial empiric treatment. Investigation identifies enteroaggregative E. coli (EAEC) through molecular methods. Code 1A03 adequately captures this condition, regardless of symptom duration.

Scenario 6: Mild Self-Limited Presentation with Laboratory Confirmation A patient with mild gastrointestinal symptoms (diarrhea without blood, minimal abdominal discomfort) who provides a stool sample during investigation of contact with a confirmed case. Culture identifies pathogenic E. coli. Even in oligosymptomatic presentations, if there is laboratory confirmation, code 1A03 should be used for epidemiologic surveillance purposes.

4. When NOT to Use This Code

It is essential to distinguish situations where code 1A03 is not appropriate, avoiding coding errors that compromise the quality of epidemiological data:

Extraintestinal E. coli Infections: When E. coli causes infections outside the gastrointestinal tract (urinary tract infections, sepsis, neonatal meningitis, wound infections), specific codes for these conditions should be used, not 1A03. This code is exclusive to gastrointestinal manifestations.

Asymptomatic Colonization: The mere presence of E. coli in feces, without clinical manifestations of gastrointestinal infection, does not justify the use of this code. E. coli is part of the normal intestinal microbiota, and its detection without symptoms does not constitute a codifiable disease.

Gastroenteritis of Other Etiology: When investigation confirms another causative agent (Salmonella, Campylobacter, Rotavirus, Norovirus), even if E. coli is detected concomitantly as a colonizer, the appropriate code is that of the pathogenic agent confirmed as the cause of symptoms.

Antibiotic-Associated Diarrhea: Diarrheal conditions related to antimicrobial use, especially when associated with Clostridioides difficile, require specific codes for this condition and should not be coded as E. coli infection even if this bacterium is present.

Irritable Bowel Syndrome: Patients with an established diagnosis of irritable bowel syndrome who present with chronic or recurrent symptoms should not receive code 1A03 unless there is confirmation of acute E. coli infection superimposed on the chronic condition.

Isolated Systemic Complications: When a patient develops hemolytic-uremic syndrome (HUS) following EHEC infection, but the coding specifically refers to the already established HUS (without active diarrhea), the primary code should reflect the renal complication, with 1A03 as a secondary or historical code as appropriate.

5. Step-by-Step Coding Process

Step 1: Assess Diagnostic Criteria

Confirmation of the diagnosis of intestinal infection by E. coli requires careful evaluation combining clinical and laboratory elements. Clinically, the patient should present gastrointestinal symptoms such as diarrhea (watery or bloody), abdominal cramps, nausea, vomiting, or tenesmus. Epidemiological history is valuable: exposure to potentially contaminated food or water, recent travel, contact with confirmed cases, or participation in known outbreaks.

Ideal laboratory confirmation includes stool culture with identification of pathogenic E. coli and characterization of the pathotype through virulence testing (toxin detection, virulence genes by PCR, serotyping). Direct molecular methods on fecal samples have become increasingly available, offering faster diagnosis. In outbreak contexts, strong epidemiological association with confirmed cases may justify clinical diagnosis even without individual confirmation.

Assessment should include signs of severity: dehydration, electrolyte abnormalities, signs of systemic complications (hemolytic anemia, thrombocytopenia, renal insufficiency suggestive of HUS). Complementary tests such as complete blood count, renal function, and electrolytes aid in severity assessment but do not confirm etiological diagnosis.

Step 2: Verify Specifiers

Code 1A03 allows additional specification when the coding system accommodates subcategories. Identify the pathotype if known: ETEC (enterotoxigenic), EPEC (enteropathogenic), EHEC/STEC (enterohemorrhagic/Shiga toxin-producing), EIEC (enteroinvasive), EAEC (enteroaggregative), or DAEC (diffuse adherence). Each pathotype has distinct clinical and epidemiological implications.

Classify severity: mild (minimal symptoms, no dehydration), moderate (mild to moderate dehydration, significant symptoms but manageable on an outpatient basis), or severe (severe dehydration, abundant bloody diarrhea, need for hospitalization, systemic complications). Duration is also relevant: acute (less than 14 days) or persistent (14 days or more).

Document specific clinical features: presence of blood in stool, fever, significant vomiting, signs of dehydration. This information, although not changing the main code, is essential for complete clinical documentation and may influence additional codes.

Step 3: Differentiate from Other Codes

1A00 - Cholera: The fundamental differentiation is the etiological agent. Cholera is caused by Vibrio cholerae, classically presenting with profuse watery diarrhea "rice-water stools," rapidly progressive dehydration, and potential for hypovolemic shock within hours. E. coli, even ETEC which can cause significant watery diarrhea, generally presents with less fulminant progression and distinct clinical characteristics.

1A01 - Intestinal Infection by Other Bacteria of the Genus Vibrio: This code encompasses infections by Vibrio parahaemolyticus, V. vulnificus, and other non-cholerae species. Differentiation is purely microbiological - the isolated agent determines the code. Clinically, Vibrio parahaemolyticus infections are frequently associated with seafood consumption and may cause bloody diarrhea, but definitive diagnosis requires laboratory identification.

1A02 - Intestinal Infections by Shigella: Shigellosis is characterized by dysentery (bloody diarrhea with mucus and pus), high fever, tenesmus, and severe abdominal pain. Although EIEC and Shigella are genetically related and may cause similar presentations, microbiological identification clearly differentiates them. Shigella has greater tropism for the distal colon and rectum, frequently causing severe proctitis.

Step 4: Necessary Documentation

For appropriate coding, clinical documentation should include:

Mandatory Checklist:

Clear description of gastrointestinal symptoms (type of diarrhea, frequency, presence of blood/mucus)
Date of symptom onset and duration
Laboratory test results, especially stool culture or molecular tests
Specific identification of E. coli as the etiological agent
Pathotype if determined
Severity assessment and presence of complications
Relevant epidemiological history
Treatment instituted

Appropriate Record: The medical record should clearly establish the causal relationship between E. coli and gastrointestinal symptoms. Phrases such as "acute gastroenteritis by enterohemorrhagic E. coli confirmed by culture" or "traveler's diarrhea, stool culture positive for enterotoxigenic E. coli" facilitate precise coding. Avoid ambiguities such as "diarrhea, E. coli isolated in stool" without establishing causal relationship.

6. Complete Practical Example

Clinical Case

A 42-year-old female patient, previously healthy, presents to the emergency department with a complaint of diarrhea for 3 days. She reports that symptoms began approximately 36 hours after attending a social event where she consumed undercooked hamburgers. Initially, she presented with watery diarrhea, 4-5 episodes per day, accompanied by moderate abdominal cramping. On the second day, she noticed the appearance of bright red blood in the stool, with intensification of abdominal pain. She denies significant fever (reported axillary temperature of 37.8°C on one occasion), but reports nausea and one episode of vomiting.

On physical examination: patient alert, oriented, mucous membranes slightly dry, skin turgor preserved. Axillary temperature: 37.2°C. Heart rate: 92 bpm. Blood pressure: 118/76 mmHg. Abdomen: increased bowel sounds, diffuse pain on palpation, more intense in the left iliac fossa and hypogastrium, without signs of peritoneal irritation, without masses or visceromegaly.

Laboratory tests ordered:

Complete blood count: white blood cells 11,200/mm³ (without left shift), hemoglobin 13.2 g/dL, platelets 245,000/mm³
Urea: 42 mg/dL, creatinine: 0.9 mg/dL
Electrolytes within normal limits
Stool culture: ordered
Fecal leukocyte search: positive

The patient was counseled on oral hydration, rest, light diet, and follow-up for reevaluation. Antibiotic therapy was deliberately not initiated due to suspicion of enterohemorrhagic E. coli (based on the presentation of bloody diarrhea without significant fever following consumption of undercooked meat), as antimicrobial agents may increase the risk of hemolytic-uremic syndrome in this context.

After 5 days, the laboratory confirmed isolation of Shiga toxin-producing E. coli O157:H7. The patient returned for reevaluation, reporting progressive improvement of symptoms, with no new episodes of bloody diarrhea in the last 24 hours. Follow-up tests showed preserved renal function and complete blood count without abnormalities, ruling out development of HUS.

Step-by-Step Coding

Criteria Analysis:

Confirmed gastrointestinal manifestations: Watery diarrhea progressing to bloody diarrhea, abdominal cramping - criterion met
Etiological confirmation: Stool culture positive for E. coli O157:H7 (EHEC/STEC) - criterion definitively met
Exclusion of other etiologies: Clinical presentation and laboratory confirmation exclude other bacterial causes
Absence of extraintestinal complications: Preserved renal function, without hemolytic anemia, without thrombocytopenia - infection limited to the gastrointestinal tract

Code Selected: 1A03

Complete Justification:

The code 1A03 (Intestinal infections due to Escherichia coli) is the appropriate primary code because:

The official definition specifies "any condition of the gastrointestinal system caused by infection by the gram-negative bacterium Escherichia coli" - exactly what this case represents
There is unequivocal laboratory confirmation of the etiological agent (E. coli O157:H7)
Clinical manifestations are exclusively gastrointestinal
There are no systemic complications that would require alternative codes as primary

Applicable Complementary Codes:

Depending on the coding system and documentation needs, the following could be added:

Code for dehydration (if the system requires separate coding of complications)
Code for external cause related to contaminated food (if available in the local ICD-11 structure)
Specification of serotype O157:H7 if the system allows this level of detail

Medical Record Documentation to Support Coding:

"Acute gastroenteritis due to Escherichia coli O157:H7 confirmed by stool culture. Presentation of hemorrhagic colitis with favorable progression, without development of hemolytic-uremic syndrome. Probable source: consumption of undercooked beef."

This clear documentation allows for precise coding, appropriate epidemiological tracking, and provides essential information for foodborne outbreak surveillance.

7. Related Codes and Differentiation

Within the Same Category

1A00: Cholera

When to use 1A00 vs. 1A03: Use 1A00 exclusively when Vibrio cholerae is identified as the etiologic agent. Cholera presents with characteristic profuse watery diarrhea ("rice water" stools), often with sudden onset and rapidly progressive dehydration. Differentiation is microbiological - culture identifies V. cholerae instead of E. coli.

Main difference: Distinct etiologic agent (Vibrio cholerae vs. Escherichia coli) and, generally, more dramatic clinical presentation in cholera, with potential for severe dehydration within hours. Epidemiologically, cholera is associated with specific endemic areas and outbreaks related to poor sanitary conditions, whereas E. coli has more universal distribution.

1A01: Intestinal Infection by Other Bacteria of the Vibrio Genus

When to use 1A01 vs. 1A03: Code 1A01 is appropriate when culture identifies Vibrio species other than V. cholerae (such as V. parahaemolyticus, V. vulnificus, V. mimicus). These infections are frequently associated with consumption of raw or undercooked seafood.

Main difference: Again, differentiation is microbiological. Clinically, V. parahaemolyticus can cause gastroenteritis with bloody diarrhea similar to some presentations of E. coli, but laboratory identification of the Vibrio genus directs toward 1A01. V. vulnificus, although it can cause gastroenteritis, more frequently causes severe skin infections and sepsis in individuals with chronic liver disease.

1A02: Intestinal Infections by Shigella

When to use 1A02 vs. 1A03: Use 1A02 when Shigella spp. (S. dysenteriae, S. flexneri, S. boydii, S. sonnei) is identified. Shigellosis classically causes bacillary dysentery with high fever, bloody diarrhea with mucus and pus, intense tenesmus, and severe abdominal pain.

Main difference: Although enteroinvasive E. coli (EIEC) is genetically related to Shigella and can cause similar clinical presentation, microbiological identification clearly differentiates them. Shigella has a very low infectious dose (10-100 organisms), facilitating person-to-person transmission, whereas E. coli generally requires a larger inoculum. Epidemiologically, shigellosis is more common in crowded settings (daycare centers, institutions) due to ease of transmission.

Differential Diagnoses

Other Bacterial Intestinal Infections: Salmonella (1A04-1A05), Campylobacter, Yersinia, and other enteric bacteria can cause overlapping clinical presentations. Definitive differentiation requires stool culture or molecular methods. Clinically, high and prolonged fever suggests Salmonella more; severe abdominal pain simulating appendicitis may indicate Yersinia; bloody diarrhea in the context of poultry consumption suggests Campylobacter.

Viral Gastroenteritis: Rotavirus, Norovirus, and other enteric viruses cause watery diarrhea, but generally with more prominent vomiting, shorter duration (24-72 hours), and absence of blood in stools. Bloody diarrhea virtually excludes viral etiology.

Inflammatory Bowel Diseases: Ulcerative colitis and Crohn's disease can present with bloody diarrhea, but typically have chronic or recurrent evolution, not acute. Previous history, endoscopic findings, and histopathologic features differentiate them.

Ischemic Colitis: In elderly patients with cardiovascular risk factors, sudden bloody diarrhea may represent intestinal ischemia. Abdominal pain disproportionate to physical examination findings, advanced age, and absence of fever are important clues.

8. Differences with ICD-10

Equivalent ICD-10 Code: A04 (Other bacterial intestinal infections), with specific subcategories such as A04.0-A04.4 for different pathotypes of E. coli.

Main Changes in ICD-11:

ICD-11 introduced the consolidated code 1A03 for all intestinal infections caused by E. coli, representing a simplification compared to ICD-10, which distributed different pathotypes across multiple codes (A04.0 for EPEC, A04.1 for ETEC, A04.2 for EIEC, A04.3 for EHEC, A04.4 for other enteroinvasive E. coli). This consolidation reflects the recognition that, although pathogenicity mechanisms vary, the common etiologic agent and shared transmission route justify grouping for epidemiological purposes.

The ICD-11 structure allows additional extensions and specifications when needed to detail the specific pathotype, maintaining flexibility for detailed clinical documentation while facilitating aggregated analyses. The terminology was updated to reflect contemporary microbiological knowledge, and the hierarchy was reorganized for better alignment with current microbiological classification systems.

Practical Impact:

For coders, the transition means learning a single code (1A03) instead of memorizing multiple codes for different pathotypes. For epidemiological surveillance systems, it facilitates aggregated tracking of E. coli infections, although systems that wish to monitor specific pathotypes (particularly EHEC/STEC due to HUS risk) need to implement extensions or additional fields. For researchers, the change requires attention when comparing historical data coded in ICD-10 with current data in ICD-11, necessitating appropriate conversion tables.

9. Frequently Asked Questions

How is the diagnosis of intestinal infection by E. coli made?

Definitive diagnosis requires laboratory confirmation through fecal culture or molecular methods (PCR). The fecal sample should preferably be collected before the start of antibiotic therapy and sent to the laboratory in appropriate transport medium. Traditional culture identifies E. coli and allows characterization of the pathotype through virulence testing, serotyping, or detection of specific genes. Multiplex molecular methods, increasingly available, simultaneously detect multiple enteric pathogens and virulence genes, providing results more rapidly (24-48 hours vs. 3-5 days for culture). Presumptive clinical diagnosis can be made based on characteristic symptoms and epidemiological context, but laboratory confirmation is essential for public health surveillance and outbreak management.

Is treatment available in public health systems?

Yes, treatment of intestinal infections by E. coli is widely available in public health systems globally. The basis of treatment is supportive therapy with oral or intravenous hydration, depending on the severity of dehydration. Oral rehydration solutions are low-cost and highly effective for mild to moderate cases. The use of antibiotics is controversial and generally not recommended, especially in EHEC/STEC infections, where antimicrobials may increase the risk of hemolytic-uremic syndrome. Antidiarrheal agents are also contraindicated in bloody diarrhea. Most cases resolve spontaneously with adequate support, making treatment accessible even in resource-limited settings.

How long does treatment last?

The duration of illness varies according to the pathotype and severity. ETEC infections (traveler's diarrhea) typically last 3-5 days with supportive treatment. EPEC can cause more prolonged diarrhea, especially in infants, lasting 1-2 weeks. EHEC/STEC generally resolves in 5-7 days, but requires monitoring for up to 2 weeks for early detection of hemolytic-uremic syndrome. EAEC can cause persistent diarrhea (more than 14 days) in some cases. Supportive treatment with hydration continues while significant diarrhea persists. Patients should be counseled about warning signs requiring reevaluation: worsening dehydration, decreased urine output, severe bleeding, neurological changes, or development of jaundice.

Can this code be used in medical certificates?

Yes, code 1A03 can and should be used in medical certificates when appropriate. For work or school absence certificates, the description can be more generic ("acute gastroenteritis") or specific ("intestinal infection by E. coli") according to patient preference and local requirements. Absence from work is particularly important for food handlers, healthcare professionals, and children in daycare settings, and should extend until complete resolution of symptoms. Some settings require negative fecal culture before return, especially in outbreaks. The duration of the certificate varies according to severity: mild cases may require 3-5 days, while moderate to severe cases may require 7-14 days. Complications such as HUS may require prolonged absences.

What are the signs of serious complications?

Warning signs include: severe dehydration (dry mucous membranes, marked decrease in urine output, tachycardia, hypotension, altered mental status), voluminous intestinal bleeding, intense and persistent abdominal pain, sustained high fever, intractable vomiting preventing oral hydration, and signs of hemolytic-uremic syndrome (decreased urine output, sudden pallor, petechiae, neurological changes such as confusion or seizures). Patients with EHEC/STEC should be especially monitored for HUS through complete blood count and renal function in the first 7-10 days. Development of HUS requires immediate hospitalization and specialized management.

How to prevent E. coli infections?

Preventive measures include: cooking meat thoroughly (especially ground meat, reaching an internal temperature of 70°C), avoiding consumption of unpasteurized milk and dairy products, properly washing raw fruits and vegetables, preventing cross-contamination in the kitchen (separating utensils for raw and cooked foods), rigorous hand hygiene (especially after using the bathroom, changing diapers, and before handling food), avoiding swallowing water from lakes or pools, and special precautions when traveling to areas with poor sanitation (avoiding food from street vendors, consuming only bottled or treated water, avoiding ice from unknown sources).

Is there a vaccine against E. coli?

Currently there is no licensed vaccine for human use against enteric E. coli, although research is ongoing. Experimental vaccines against ETEC are in development phases to prevent traveler's diarrhea. Prevention remains based on hygiene measures, food safety, and basic sanitation.

Who is at higher risk of developing severe forms?

Higher-risk groups include: children under 5 years of age (especially for EHEC/STEC with risk of HUS), elderly individuals, pregnant women, immunocompromised individuals (HIV/AIDS, chemotherapy, immunosuppressant use, transplant recipients), people with chronic diseases (kidney disease, diabetes, liver disease), and individuals with achlorhydria or antacid use (which reduce the gastric barrier). These groups should be monitored more carefully and have a lower threshold for hospitalization.

Conclusion:

The ICD-11 code 1A03 for intestinal infections by Escherichia coli represents an essential tool for clinical documentation, epidemiological surveillance, and public health management. Proper understanding of when and how to use this code, its differentiation from other bacterial intestinal infections, and appropriate clinical documentation are fundamental for healthcare professionals. The transition from ICD-10 to ICD-11 brought simplification in coding structure while maintaining the ability to specify when necessary. Recognition of the diverse clinical presentations of E. coli infections, from self-limited forms to potentially fatal complications, underscores the importance of accurate coding to adequately capture disease burden and guide public health interventions globally.

External References

This article was prepared based on reliable scientific sources:

References verified on 2026-02-03

Intestinal Infections by Escherichia coli

Compartir